GFAP and Alzheimer disease: We confirm previous findings that all four biomarkers provide predictive diagnostic value for AD, and we extend emerging findings that pTau181, GFAP and to a lesser degree NfL inform prognosis with their higher levels predicting decline in participants with MCI.